[go: up one dir, main page]

BR0012740A - Compostos para tratamento de distúrbios do sistema infeccioso e imune e métodos para seu emprego - Google Patents

Compostos para tratamento de distúrbios do sistema infeccioso e imune e métodos para seu emprego

Info

Publication number
BR0012740A
BR0012740A BR0012740-0A BR0012740A BR0012740A BR 0012740 A BR0012740 A BR 0012740A BR 0012740 A BR0012740 A BR 0012740A BR 0012740 A BR0012740 A BR 0012740A
Authority
BR
Brazil
Prior art keywords
infectious
compounds
treatment
methods
immune system
Prior art date
Application number
BR0012740-0A
Other languages
English (en)
Inventor
Alain Delcayre
Original Assignee
Genesis Res & Dev Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/351,348 external-priority patent/US6436898B1/en
Application filed by Genesis Res & Dev Corp Ltd filed Critical Genesis Res & Dev Corp Ltd
Publication of BR0012740A publication Critical patent/BR0012740A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"COMPOSTOS PARA TRATAMENTO DE DISTúRBIOS DO SISTEMA INFECCIOSO E IMUNE E MéTODOS PARA SEU EMPREGO". A presente invenção refere-se a polipeptídeos compreendendo um epítopo imunogênico de uma proteína de M. vaccae, polinucleotídeos codificando tais polipeptídeos, e proteínas de fusão compreendendo pelo menos um tal polipeptídeo, juntamente com as construções de DNA compreendendo pelo menos um polinucleotídeo inventivo. As composições compreendendo tais polipeptídeos, polinucleotídeos, proteínas de fusão e/ou construções de DNA podem ser empregadas no tratamento de doenças infecciosas e distúrbios imunes.
BR0012740-0A 1999-07-12 2000-07-10 Compostos para tratamento de distúrbios do sistema infeccioso e imune e métodos para seu emprego BR0012740A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/351,348 US6436898B1 (en) 1999-07-12 1999-07-12 Compounds for treatment of infectious and immune system disorders and methods for their use
US09/450,072 US6358734B1 (en) 1999-07-12 1999-11-29 Compounds for treatment of infectious and immune system disorders and methods for their use
PCT/NZ2000/000121 WO2001004140A1 (en) 1999-07-12 2000-07-10 Compounds for treatment of infectious and immune system disorders and methods for their use

Publications (1)

Publication Number Publication Date
BR0012740A true BR0012740A (pt) 2002-05-28

Family

ID=26997051

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0012740-0A BR0012740A (pt) 1999-07-12 2000-07-10 Compostos para tratamento de distúrbios do sistema infeccioso e imune e métodos para seu emprego

Country Status (9)

Country Link
US (1) US7041295B2 (pt)
EP (1) EP1200459B1 (pt)
JP (1) JP2003504079A (pt)
CN (1) CN100379759C (pt)
AU (1) AU784847B2 (pt)
BR (1) BR0012740A (pt)
CA (1) CA2383496A1 (pt)
MX (1) MXPA01013097A (pt)
WO (1) WO2001004140A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004280630A1 (en) * 2003-10-10 2005-04-21 Powderject Vaccines, Inc. Method
CN102961760B (zh) * 2011-09-01 2017-07-18 常州文松生物技术有限公司 重叠肽作为制备皮肤试验和检测特异性细胞免疫的试剂及其应用
CN103063836B (zh) * 2011-10-18 2016-03-30 复旦大学附属华山医院 检测分枝杆菌感染的试剂、方法和试剂盒

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6284255B1 (en) * 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
HUP0100352A2 (hu) * 1997-12-23 2001-06-28 Genesis Research & Development Corporation Limited Mycobacterium vaccaeből származó kompozíciók és eljárások ezek alkalmazására
US6436898B1 (en) * 1999-07-12 2002-08-20 Genesis Research And Development Corporation Limited Compounds for treatment of infectious and immune system disorders and methods for their use
US7192590B2 (en) * 1999-07-12 2007-03-20 Genesis Research And Development Corporation, Ltd. Compounds for treatment of infectious and immune system disorders and methods for their use

Also Published As

Publication number Publication date
MXPA01013097A (es) 2002-06-04
EP1200459B1 (en) 2007-11-21
EP1200459A4 (en) 2005-06-01
CA2383496A1 (en) 2001-01-18
AU784847B2 (en) 2006-07-06
JP2003504079A (ja) 2003-02-04
WO2001004140A1 (en) 2001-01-18
EP1200459A1 (en) 2002-05-02
US7041295B2 (en) 2006-05-09
CN1378560A (zh) 2002-11-06
AU5719700A (en) 2001-01-30
US20030054013A1 (en) 2003-03-20
CN100379759C (zh) 2008-04-09

Similar Documents

Publication Publication Date Title
GEP20022695B (en) Moraxella Catarrhalis Outer Membrane Protein-106 Polypeptide, Gene Sequence and Uses Thereof
DK0662827T4 (da) Terapeutiske og diagnostiske fremgangsmåder og sammensætninger baseret på Notch-proteiner og nucleinsyrer
GR3034140T3 (en) CD2-Binding domain of lymphocyte function associated antigen 3.
DK382786A (da) Overfladeaktivt rekombinant-alveolarprotein
BR0007840A (pt) Proteìnas de fusão her-2/neu
DK0625989T3 (da) DNA-sekvenser kodende for hidtil ukendte vækst-/differentieringsfaktorer
ATE127345T1 (de) Stressproteine und verwendungen dafür.
DE69630457D1 (de) Verbindungen zur immunotherapie und diagnose von tuberkulose
BR9711457A (pt) Compostos e processo para o tratamento e diagnóstico de infecções micobacterianas.
DE69922958D1 (de) Hcv hüllproteine partikel : verwendung für therapeutische impfung
ES2168361T3 (es) Secuencias de adn para metaloproteasas de la matriz, su preparacion y empleo.
PT84089A (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
MX9203138A (es) Dominio de enlace cd2-de antigeno 3 (lfa-3) asociado con funcion linfositos.
FI885237A7 (fi) Menetelmä yhdistelmä-E. colissa ilmennetyn P. falciparum-CS-proteiinir okotteen eristämiseksi ja puhdistamiseksi
WO1996018646A3 (en) Heat shock protein peptides and methods for modulating autoimmune central nervous system disease
EP0369816A3 (en) Monoclonal antibodies specific for human polymorphic epithelial mucin
BR0012740A (pt) Compostos para tratamento de distúrbios do sistema infeccioso e imune e métodos para seu emprego
EP0250000A3 (en) Polypeptides, their preparation and their use
BR9713096A (pt) Lactação bovina associada à proteìna imunotrópica (cd14), gene codificado e aplicação na ativação de célula b
NO890174L (no) Rekombinante interleukin-1alfa-polypeptider.
PT524421E (pt) Herpesvirus humano tipo 6 proteina p 100, sequencias de adn correspondentes, preparacao e utilizacao
EP0315081A3 (en) Anti-coagulating protein pp4-x, its preparation and use
AU1948788A (en) Expression of immunologically active proteins of human b-lymphotropic virus
EP0723016A3 (en) Leukocyte activation factor
EP0497911A4 (en) Recombinant production of lactoperoxidase

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]